Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements regarding to Financial Results of the Company for the quarter ended June 30, 2020. The advertisements as appeared on August 18, 2020 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements
18-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Please find attached Investor Presentation
17-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Board recommends Bounus Issue

 Suven Pharmaceuticals Ltd has informed BSE about Outcome of Board Meeting held on August 17, 2020.
17-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Outcome Of The Board Meeting

 Issue of Bonus Shares The Board of Directors has considered, approved and recommended issue of (1:1) one Bonus Share for every one equity share held by the equity shareholders of the Company. The bonus issue of equity shares is subject to the approval of the shareholders in the ensuing annual general meeting and any other applicable statutory and regulatory approvals, as may be required. The Bonus shares once allotted shall rank pari-passu in all respects and carry the same rights of the existing Equity Shares and shall be entitled to participate in full in any dividend and other corporate action, recommended and declared, if any, after the issue and allotment of such Bonus Shares. The details pertaining to the Bonus issue of equity shares as per Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is provided at Annexure- A.
17-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Outcome Of The Board Meeting

 With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. August 17, 2020, approved the following along with other business matters. 1) Took on record and approved the attached Un-audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter ended 30th June, 2020 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Limited Review Reports of the Statutory Auditors. 2) e-Annual General Meeting The Second Annual General Meeting of the Company will be held on Monday the 14th day of September, 2020 at 11.30 a.m. IST
17-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Tuesday, August 18, 2020 at 12:00 Noon IST to discuss the Un-audited Financial Results for the Q1 Financial Year 2021, to be declared on August 17, 2020.
13-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated August 10, 2020 regarding to Notice of Board Meeting, please find enclosed the copies of the newspaper advertisements as appeared today i.e. August 11, 2020 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at: https://www.suvenpharm.com/index.php/investors/corporate-info/advertisements
11-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Board to consider Bonus Issue

 Suven Pharmaceuticals Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on August 17, 2020, inter alia, to consider, and approve the following matter(s):1. The Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the first quarter ended June 30, 2020 and related matters2. Suven Pharma Employee Stock Option Scheme 2020 under SEBI (Share Based Employee Benefits) Regulations, 20143. Increase in Authorised Capital and 4. Issue of Bonus SharesFurther, TRADING WINDOW for dealing in the securities of the company is already closed from 01st July, 2020 as per PIT Code of the Company. Trading window will be opened from 20th August, 2020.
10-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Monday, The 17Th August, 2020

 Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2020 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Monday, the 17th August, 2020 at 11:30 a.m. at the Registered Office, SDE Serene Chambers, 3rd Floor, Road No 5, Banjara Hills, Hyderabad - 500034 of the Company, to consider, inter alia, and approve the following matter(s): 1) The Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the first quarter ended June 30, 2020 and related matters 2) Suven Pharma Employee Stock Option Scheme 2020 under SEBI (Share Based Employee Benefits) Regulations, 2014 3) Increase in Authorised Capital and 4) Issue of Bonus Shares Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st July, 2020 as per PIT Code of the Company. Trading window will be opened from 20th August, 2020.
10-08-2020
Bigul

Suven Pharmaceuticals Ltd - 543064 - Statement Of Investor Complaints For The Quarter Ended June 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 027270 Name of the Signatory :- K HANUMANTHA RAODesignation :- Company Secretary and Compliance Officer
21-07-2020
Next Page
Close

Let's Open Free Demat Account